Press Releases
Filters
October 13, 2021
Viatris Inc. to Release Third Quarter 2021 Financial Results on Nov. 8, 2021
July 28, 2021
Viatris Inc. and Biocon Biologics Receive Historic Approval for First Interchangeable Biosimilar Semglee® (insulin glargine-yfgn injection) for the Treatment of Diabetes
July 8, 2021
Viatris Inc. to Release Second Quarter 2021 Financial Results on Aug. 9, 2021
June 23, 2021
Mylan Wins Significant Summary Judgment Rulings in Kansas EpiPen® Class Action
May 25, 2021
Viatris Inc. to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference
Displaying 111 - 120 of 137